<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">3047</id>
  <title>T3D3005</title>
  <common-name>Orphenadrine</common-name>
  <description>Orphenadrine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. [PubChem] Orphenadrine binds and inhibits both histamine H1 receptors and NMDA receptors. It restores the motor disturbances induced by neuroleptics, in particular the hyperkinesia. The dopamine deficiency in the striatum increases the stimulating effects of the cholinergic system. This stimulation is counteracted by the anticholinergic effect of orphenadrine. It may have a relaxing effect on skeletal muscle spasms and it has a mood elevating effect.</description>
  <cas>83-98-7</cas>
  <pubchem-id>4601</pubchem-id>
  <chemical-formula>C18H23NO</chemical-formula>
  <weight>269.177960</weight>
  <appearance nil="true"/>
  <melting-point>&lt; 25°C</melting-point>
  <boiling-point>195°C at 1.20E+01 mm Hg</boiling-point>
  <density nil="true"/>
  <solubility>Sparingly soluble in water</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Orphenadrine is almost completely absorbed in the gastrointestinal tract.</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Orphenadrine binds and inhibits both histamine H1 receptors and NMDA receptors. It restores the motor disturbances induced by neuroleptics, in particular the hyperkinesia. The dopamine deficiency in the striatum increases the stimulating effects of the cholinergic system. This stimulation is counteracted by the anticholinergic effect of orphenadrine. It may have a relaxing effect on skeletal muscle spasms and it has a mood elevating effect.</mechanism-of-toxicity>
  <metabolism>Biotransformation occurs mainly in the liver. Pharmacologically active metabolites are N-demethyl orphenadrine and N,N-didemethyl orphenadrine.Half Life: 13-20 hours</metabolism>
  <toxicity>LD50: 100 mg/kg (Oral, Mouse) (A308)LD50: 255 mg/kg (Oral, Rat) (A308)</toxicity>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>Indicated for the treatment of Parkinson's disease.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms></symptoms>
  <treatment>Treatment for orphenadrine overdose is evacuation of stomach contents (when necessary), charcoal at repeated doses, intensive monitoring, and appropriate supportive treatment of any emergent anticholinergic effects. (L1712)</treatment>
  <created-at type="dateTime">2009-07-21T20:28:31Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:25:55Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Orphenadrine</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C07935</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>7789</chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Orphenadrine</stitch-id>
  <drugbank-id>DB01173</drugbank-id>
  <pdb-id></pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1C</moldb-smiles>
  <moldb-formula>C18H23NO</moldb-formula>
  <moldb-inchi>InChI=1/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3</moldb-inchi>
  <moldb-inchikey>InChIKey=QVYRGXJJSLMXQH-UHFFFAOYNA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">269.3813</moldb-average-mass>
  <moldb-mono-mass type="decimal">269.177964363</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Liquid</state>
  <logp>3.77</logp>
  <hmdb-id>HMDB15304</hmdb-id>
  <chembl-id>CHEMBL900</chembl-id>
  <chemspider-id>4440</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
